Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Oncotarget|August 6, 2015
Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphomaNina A Sibbesen, Katharina L Kopp, Ivan V Litvinov, et al.
Breast Cancer Research and Treatment|July 20, 2011
Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium membersMads Thomassen, Ana Blanco, Marco Montagna, et al.
Oncotarget|June 23, 2016
STAT5 induces miR-21 expression in cutaneous T cell lymphomaLise M Lindahl, Simon Fredholm, Claudine Joseph, et al.
Breast Cancer Research : BCR|July 2, 2013
COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration, Melissa C Southey, Daniel J Park, et al.
Journal of the National Cancer Institute|December 21, 2010
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriersSusan J Ramus, Christiana Kartsonaki, Simon A Gayther, et al.
Human Molecular Genetics|May 20, 2011
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriersAntonis C Antoniou, Christiana Kartsonaki, Olga M Sinilnikova, et al.
Cancer Research|December 2, 2010
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk predictionAntonis C Antoniou, Jonathan Beesley, Lesley McGuffog, et al.
Plos Genetics|April 5, 2014
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersAna Osorio, Roger L Milne, Karoline Kuchenbaecker, et al.
Plos One|April 2, 2015
Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriersIgnacio Blanco, Karoline Kuchenbaecker, Daniel Cuadras, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 2014
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersPaolo Peterlongo, Jenny Chang-Claude, Kirsten B Moysich, et al.
Pageof 5